MARN: Perspectives from the developing world
With the Covid-19 pandemic placing global health systems under extreme pressure, there is a growing need for novel, accurate diagnostic assays across the world.
Type of Event
Virtual Event
Our Participation
Sponsor
With the Covid-19 pandemic placing global health systems under extreme pressure, there is a growing need for novel, accurate diagnostic assays across the world. Reliable diagnostic methods have always been critical for health prosperity. Our 3rd MARN (MilliporeSigma Middle East and Africa Network) event will highlight the incredible work being done in the diagnostic space in Africa and in the Middle East. Our speakers are experts in the development of novel diagnostic solutions and our company is privileged to offer the opportunity to hear their perspectives, learn from their challenges and get inspired by their successes.
Attendees will have the opportunity to learn about:
- Successful business models for developing diagnostics
- Innovations in the diagnostic space
- Lessons learned from combating Covid-19, Ebola and other prevalent Pathogens in Africa
- The Global Health Institute of Merck KGaA, Darmstadt, Germany: From Research & Development To Access for new diagnostics for Neglected Tropical Diseases
- Developing home grown solutions to global problems
Speakers
Prof. Zeleke Mekonnen (PhD): Director of Health Research and Innovation at the Jimma University Institute of Health - ETHIOPIA
Prof. Steve Ahuka Mundeke (MD, MTM, PhD): Head of Medical Biology Department, Kinshasa Teaching School of Medicine, University of Kinshasa and Incident Manager of Covid-19 pandemic Response, Kinshasa - DEMOCRATIC REPUBLIC OF CONGO
Charles Faul: Founder and CEO of Akili Labs – REPUBLIC OF SOUTH AFRICA
Prof. Hassan Sefrioui (MS; Ph.D.): Director of Biotechnology & Member of the Executive Board at Moroccan foundation for Advanced Science, Innovation and Research (MAScIR) - MOROCCO
Béatrice Gréco (PhD): Head of Research, Development and Access within the Global Health Institute of Merck KGaA, Darmstadt, Germany
Raik Grünberg (PhD): Research Scientist in the Computational Bioscience Center at King Abdullah University of Science and Technology (KAUST) - KINGDOM OF SAUDI ARABIA